Rybelsus 7mg (Semaglutide) is an innovative oral diabetes medication designed to help adults with Type 2 Diabetes Mellitus control their blood sugar levels. Manufactured by Novo Nordisk, Rybelsus is a GLP-1 receptor agonist and the first oral form of Semaglutide. It helps regulate blood sugar, supports weight management, and reduces the risk of cardiovascular complications.
Rybelsus, with the active ingredient semaglutide, belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists. It is used in the treatment of type 2 diabetes mellitus to improve glycemic control. Semaglutide works by mimicking the action of endogenous GLP-1, a hormone released by the intestine in response to food intake. By binding to and activating GLP-1 receptors in pancreatic beta cells, semaglutide stimulates insulin secretion in a glucose-dependent manner. It also suppresses glucagon secretion, slows gastric emptying, and promotes satiety, which collectively contribute to lower blood sugar levels.
Take one Rybelsus 7mg tablet once daily, on an empty stomach.
Swallow with a small amount of water (no more than 4 ounces).
Wait at least 30 minutes before eating, drinking, or taking other medicines.
Follow your doctor’s prescribed dosage and do not skip doses.
WellnessOne Liquid Copper Supplements - Mineral Ultra Concentrate In Pakistan
Rs : 4500 Rs : 3450 - 23% Off
Customers Reviews For Rybelsus 7 mg Tablets in Pakistan